Metformin XR, 500 mg

DRUG4 trials

Sponsors

Janssen Research & Development, LLC

Conditions

HealthyHealthy Volunteers

Phase 1

A Bioequivalence Study of the Fixed Dose Combination Tablets of Canagliflozin and Metformin Extended Release (XR) With Respect to the Individual Components

CompletedNCT02065752

Janssen Research & Development, LLCHealthy Volunteers

Start: 2014-02-28End: 2014-04-30Updated: 2014-06-17

A Bioequivalence Study of the Fixed Dose Combination Tablets of Canagliflozin and Metformin Extended Release (XR) With Respect to the Individual Components in Healthy Fed Participants

CompletedNCT02071368

Janssen Research & Development, LLCHealthy

Start: 2014-02-28End: 2014-05-31Updated: 2014-07-01

A Bioequivalence Study of the Fixed Dose Combination Tablets of Canagliflozin and Metformin Extended Release (XR) With Respect to the Individual Components

CompletedNCT02073227

Janssen Research & Development, LLCHealthy Volunteers

Start: 2014-02-28End: 2014-06-30Updated: 2014-09-09

A Bioequivalence Study of the Fixed Dose Combination Tablets of Canagliflozin and Metformin Extended Release (XR) With Respect to the Individual Components in Healthy Fed Participants

CompletedNCT02077803

Janssen Research & Development, LLCHealthy

Start: 2014-03-31End: 2014-07-31Updated: 2014-09-03